Lynx1 Capital Management LP Portfolio Holdings

Lynx1 Capital Management LP

  • $270 Million
  • Q1 2025

Lynx1 Capital Management LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $270 Million distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Gh Research PLC with a value of $71.1M, Merus N.V. with a value of $66M, Protagonist Therapeutics, Inc with a value of $35.4M, Stoke Therapeutics, Inc. with a value of $35.2M, and Cullinan Oncology, Inc. with a value of $24.3M.

Examining the 13F form we can see an increase of $13M in the current position value, from $257M to 270M.

Lynx1 Capital Management LP is based out at San Juan, PR

Below you can find more details about Lynx1 Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $270 Million
Healthcare: $270 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$34.8M
$7.39 Million 2.73% of portfolio
5,357,347
Q4 2024 Added 2.54%

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $270 Million
  • Prior Value $257 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Lynx1 Capital Management LP Portfolio

Follow Lynx1 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynx1 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Lynx1 Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email